Semaglutide is a GLP-1 receptor agonist used in medical weight-management care. A licensed provider can review your health history, goals and relevant clinical factors to determine whether treatment is appropriate for you.
Semaglutide is a GLP-1 receptor agonist studied in metabolic and weight-management research. It is given by subcutaneous injection.
A licensed provider may consider semaglutide within a medical weight-management plan based on your health history and clinical factors. It is not offered as a treatment for any specific outcome.
A licensed provider reviews your intake, health history and, where appropriate, recent labs before deciding whether any treatment is suitable.
If treatment is appropriate, the provider explains the plan, the monitoring and the follow-up.
Eligibility, dosing, side effects and alternatives are discussed with your provider. Not every patient is a candidate.
Whether any treatment is appropriate is decided by a licensed provider after an individual evaluation. Payment does not guarantee a prescription.
Start Your Assessment